Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

8,709 total articles

Accenture: Valuation Edge and AI Muscle Make it Worth a Re-rating

Accenture: Valuation Edge and AI Muscle Make it Worth a Re-rating

Accenture is a lower-risk way to play enterprise AI adoption and managed services. The stock has been punished despite healthy cash flow, a modest debt load, and ongoing AI investments. At roughly $117.6B market cap and a P/E near 15.5, the risk/reward favors a long position with a clear stop and a target that assumes a modest multiple re-rating al…

Why Novo Nordisk May Face Further Downside as the GLP-1 Fight Intensifies

Why Novo Nordisk May Face Further Downside as the GLP-1 Fight Intensifies

Novo Nordisk sits at the center of an increasingly binary GLP-1 fight. Eli Lilly's recent drug approvals and a stronger clinical edge for some pipeline assets increase the odds of market-share losses; Novo's valuation looks reasonable on paper but may not price in near-term revenue pressure. This trade idea proposes a mid-term short to capture furt…

Volkswagen: Execution Visibility Is Improving — Buy Confirmed

Volkswagen: Execution Visibility Is Improving — Buy Confirmed

Volkswagen ADR (VWAGY) offers an asymmetric setup: a $53.7B market cap, single-digit P/E (7.0), and a 4.3% dividend yield priced into a stock that is bottoming technically. With positive MACD momentum, rising short interest that could fuel squeezes, and tangible progress on partnerships and software monetization, we prefer a tactical long. Entry, s…

Buy Credo (CRDO): Acquisition and Momentum Make the Bear Case Stale

Buy Credo (CRDO): Acquisition and Momentum Make the Bear Case Stale

Credo is executing into the AI connectivity upgrade cycle. The DustPhotonics acquisition, blistering revenue growth and strong margins remove the worst of the bear arguments. This is a tactical-to-position trade: enter on strength or small pullback, protect with a defined stop, and ride a re-rating as optical revenue and AEC momentum compound.

CME Group: Buy the Yield, Hold for Volatility-Driven Upside

CME Group: Buy the Yield, Hold for Volatility-Driven Upside

CME Group (CME) offers a rare combination for income-oriented investors: a high-quality exchange operator with $4.2B in free cash flow last year, a $7.45 per-share distribution that yields about 3.7% at current prices, and a business that benefits when markets get choppy. I like a position-sized, dividend-focused long at current levels with a clear…

CoreWeave: Core Position on the AI Data-Center Buildout

CoreWeave: Core Position on the AI Data-Center Buildout

CoreWeave sits at the nexus of GPU-driven AI demand and hyperscaler data-center spending. Recent multi-year deals with Meta and Anthropic, an enlarged $21B Meta expansion, and price increases give the company a clear runway for revenue and margin improvement. Valuation is rich for a loss-making operator, but for patient, risk-tolerant investors thi…

Snowflake: Sentiment Snapped — Sell Puts, Not Stocks

Snowflake: Sentiment Snapped — Sell Puts, Not Stocks

Snowflake (SNOW) is trading well below its 52-week highs after a sectorwide software selloff and fresh legal headlines. Fundamentals still support long-term demand for a modern data cloud, but valuation and momentum favor option sellers today. My trade: sell cash-secured puts in the mid-term (45 trading days) to collect premium and be paid to own t…

Bloom Energy: Oracle Tie-Up Validates AI Power Strategy - Buy the Breakout

Bloom Energy: Oracle Tie-Up Validates AI Power Strategy - Buy the Breakout

Bloom Energy rallied into a breakout after reports of a commercial agreement with Oracle that validates its positioning as a data-center power provider. The company shows rising revenue momentum and improving cash flow, but valuation remains rich (market cap ~$56.3B) and leverage is high. This trade idea is a tactical long with a clear entry at $20…

Blue Owl: Buy the Redemption Panic, Not the Rumors

Blue Owl: Buy the Redemption Panic, Not the Rumors

Blue Owl (OWL) has been punished on private credit redemption headlines, but the firm's fee mix, strong free cash flow and a 52-week range that still leaves considerable upside argue for a tactical long. This trade idea outlines an entry, stop and target for a long-term recovery play and the key catalysts that would validate the thesis.

Patterson-UTI (PTEN): Drilling Activity Comes Back - Tactical Buy

Patterson-UTI (PTEN): Drilling Activity Comes Back - Tactical Buy

Patterson-UTI is positioned to benefit from a renewed run of U.S. and international drilling activity. With a market cap near $4.0B, attractive cash flow (FCF $372M), modest leverage, and a dividend yield north of 3%, PTEN offers a favorable risk/reward into what looks like the next drilling cycle leg up. Trade plan: enter $10.56, stop $8.75, targe…

Oneok Looks Like Income, Not Growth - Trade the Disconnect

Oneok Looks Like Income, Not Growth - Trade the Disconnect

Oneok (OKE) yields roughly 4.9% and benefits from higher energy prices tied to the Iran crisis, but 2026 guidance points to a growth pause while leverage is elevated and free cash flow is already largely committed to the dividend and projects. This trade idea takes a measured short stance over a mid-term horizon to capture mean reversion if fundame…

LVMH: Buy the Pullback in a Best-in-Class Luxury Franchise

LVMH: Buy the Pullback in a Best-in-Class Luxury Franchise

LVMUY has pulled back into what looks like a durable value zone after a sharp correction from its January highs. The business is diversified across resilient luxury categories, trades at a mid-20s P/E with a $273.7B market cap, and shows early technical signs of stabilized momentum. This trade plan targets a recovery toward the $130s over the next …